Literature DB >> 2782858

Penetration of doxycycline into cerebrospinal fluid in patients treated for suspected Lyme neuroborreliosis.

L Dotevall1, L Hagberg.   

Abstract

Twelve patients were treated orally with 100 mg of doxycycline twice a day (b.i.d.) and 10 patients were treated with 200 mg b.i.d. for suspected tick-borne neuroborreliosis (Lyme borreliosis). At 5 to 8 days after the start of therapy, the mean concentrations in serum were 4.7 micrograms/ml for the doxycycline dose of 100 mg b.i.d. and 7.5 micrograms/ml for 200 mg b.i.d., 2 to 3 h after the last drug administration. The corresponding levels for cerebrospinal fluid were 0.6 and 1.1 micrograms/ml. Since a doxycycline concentration in cerebrospinal fluid above the estimated MIC for Borrelia burgdorferi (0.6 to 0.7 microgram/ml) is wanted in patients treated for severe neuroborreliosis, the higher dose is preferable.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2782858      PMCID: PMC176065          DOI: 10.1128/AAC.33.7.1078

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  12 in total

1.  The penetration of doxycycline into CSF.

Authors:  H Andersson; K Alestig
Journal:  Scand J Infect Dis Suppl       Date:  1976

2.  Evaluation of a micromethod for determination of antibiotic concentrations in plasma.

Authors:  B Jalling; A S Malmborg; A Lindman; L O Boréus
Journal:  Eur J Clin Pharmacol       Date:  1972-06       Impact factor: 2.953

3.  Treatment of the early manifestations of Lyme disease.

Authors:  A C Steere; G J Hutchinson; D W Rahn; L H Sigal; J E Craft; E T DeSanna; S E Malawista
Journal:  Ann Intern Med       Date:  1983-07       Impact factor: 25.391

4.  Penetration of oral doxycycline into the cerebrospinal fluid of patients with latent or neurosyphilis.

Authors:  C W Yim; N M Flynn; F T Fitzgerald
Journal:  Antimicrob Agents Chemother       Date:  1985-08       Impact factor: 5.191

5.  Doxycycline blood levels in normal subjects after intravenous and oral administration.

Authors:  B J Leibowitz; J L Hakes; M M Cahn; E J Levy
Journal:  Curr Ther Res Clin Exp       Date:  1972-12

6.  The use of doxycycline in nervous system Borrelia burgdorferi infection.

Authors:  L Dotevall; K Alestig; P Hanner; G Norkrans; L Hagberg
Journal:  Scand J Infect Dis Suppl       Date:  1988

7.  Neurologic abnormalities of Lyme disease: successful treatment with high-dose intravenous penicillin.

Authors:  A C Steere; A R Pachner; S E Malawista
Journal:  Ann Intern Med       Date:  1983-12       Impact factor: 25.391

8.  Treatment of late Lyme borreliosis--randomised comparison of ceftriaxone and penicillin.

Authors:  R J Dattwyler; J J Halperin; D J Volkman; B J Luft
Journal:  Lancet       Date:  1988-05-28       Impact factor: 79.321

9.  Susceptibility of the Lyme disease spirochete to seven antimicrobial agents.

Authors:  S E Johnson; G C Klein; G P Schmid; J C Feeley
Journal:  Yale J Biol Med       Date:  1984 Jul-Aug

10.  Chronic meningitis and Lyme disease in Sweden.

Authors:  G T Stiernstedt; B R Sköldenberg; B Vandvik; B Hederstedt; A Gårde; G Kolmodin; H Jörbäck; B Svenungsson
Journal:  Yale J Biol Med       Date:  1984 Jul-Aug
View more
  21 in total

1.  Central Nervous System Lyme Disease.

Authors:  John J. Halperin
Journal:  Curr Infect Dis Rep       Date:  2004-08       Impact factor: 3.725

Review 2.  Lyme disease in paediatrics.

Authors:  B Cryan; D J Wright
Journal:  Arch Dis Child       Date:  1991-11       Impact factor: 3.791

3.  Outcome of intravenous azithromycin therapy in patients with complicated scrub typhus compared with that of doxycycline therapy using propensity-matched analysis.

Authors:  Mi-Ok Jang; Hee-Chang Jang; Uh Jin Kim; Joon Hwan Ahn; Seung-Ji Kang; Sook-In Jung; Hee-Young Shin; Kyung-Hwa Park
Journal:  Antimicrob Agents Chemother       Date:  2013-12-23       Impact factor: 5.191

4.  Concentrations of doxycycline and penicillin G in sera and cerebrospinal fluid of patients treated for neuroborreliosis.

Authors:  M Karlsson; S Hammers; I Nilsson-Ehle; A S Malmborg; B Wretlind
Journal:  Antimicrob Agents Chemother       Date:  1996-05       Impact factor: 5.191

Review 5.  Penetration of drugs through the blood-cerebrospinal fluid/blood-brain barrier for treatment of central nervous system infections.

Authors:  Roland Nau; Fritz Sörgel; Helmut Eiffert
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

Review 6.  Pharmacokinetics of antibacterial agents in the CSF of children and adolescents.

Authors:  Amanda K Sullins; Susan M Abdel-Rahman
Journal:  Paediatr Drugs       Date:  2013-04       Impact factor: 3.022

7.  In vitro and in vivo effects of doxycycline on Toxoplasma gondii.

Authors:  H R Chang; R Comte; J C Pechère
Journal:  Antimicrob Agents Chemother       Date:  1990-05       Impact factor: 5.191

Review 8.  [Neuroborreliosis].

Authors:  R Kaiser; V Fingerle
Journal:  Nervenarzt       Date:  2009-10       Impact factor: 1.214

Review 9.  Clinical pharmacokinetics of antibacterials in cerebrospinal fluid.

Authors:  Antonello Di Paolo; Giovanni Gori; Carlo Tascini; Romano Danesi; Mario Del Tacca
Journal:  Clin Pharmacokinet       Date:  2013-07       Impact factor: 6.447

10.  Azithromycin versus doxycycline for treatment of erythema migrans: clinical and microbiological findings.

Authors:  F Strle; V Preac-Mursic; J Cimperman; E Ruzic; V Maraspin; M Jereb
Journal:  Infection       Date:  1993 Mar-Apr       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.